Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with Gardasil’s challenges in China. It is ...

Merck KGaA (MKGAY) confirms “advanced discussions” with Springworks Therapeutics (SWTX) regarding a potential acquisition. “Merck also confirms that no legally binding agreement has been ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Stocks remain jittery on a mix of inflation worry coupled with concern over how Trump’s plan for tariffs could affect the U.S. economy ...

Doctors at MIOT International in Chennai, who had performed cross-blood transplants for close to two decades, were willing to cross the rubicon into a sector with no precedence whatsoever ...

Rob Cross beat Joe Cullen 8-3 to win the 2025 PDC ProTour season-opening Players Championship One in Wigan, where world champion Luke Littler had gone out in the third round. The Robin Park ...

Rob Cross beat Joe Cullen 8-3 to win the opening Players Championship event of 2025 in Wigan after Luke Littler lost in the third round. Cross has already won the Dutch Darts Masters last month ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

SEC Filings provided by EDGAR Online, Inc.